Status:
UNKNOWN
Evaluating Structural and Functional Changes of Brain by fMRI and DTI in Patients With Intracranial Germ Cell Tumors
Lead Sponsor:
Beijing Neurosurgical Institute
Conditions:
Intracranial Germ Cell Tumor
Eligibility:
All Genders
3+ years
Brief Summary
BOLD-fMRI and DTI scans are performed to patients with germ cell tumors in the basal ganglia before and after treatments. The changes of the MRI and muscle strength of patients during treatments are e...
Detailed Description
Primary intracranial germ cell tumors are a specific entity of brain tumors with a variety of histological types and different degrees of malignancy. Intracranial GCTs make up 11.2% - 15.3% of primary...
Eligibility Criteria
Inclusion
- age ≥3 years;
- no history of brain radiotherapy;
- no other known cause of movement and cognitive impairment;
- no contraindications to the magnetic resonance imaging (MRI) scan;
Exclusion
- patients can not tolerate MR scan;
- head motion is greater than 3 mm during functional MRI scanning.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03771625
Start Date
June 1 2019
End Date
November 1 2021
Last Update
July 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, China, 100071